{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "PARK2_UNKNOWN"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in parkin, which encodes a ubiquitin ligase, are the main contributor to familial Parkinsonâ€™s disease (PD). The study found that many disease-linked point mutants of parkin retain substantial catalytic activity, but over half of the mutations alter parkin solubility and lead to intracellular, aggresome-like protein aggregates, which may underlie the loss of function caused by these mutations.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism: parkin mutations impair function through altered solubility and aggregation, not by directly abrogating catalytic activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study analyzed the solubility and intracellular localization of parkin mutants, which are relevant to understanding their pathogenic mechanism. These assays model the molecular basis of PD caused by parkin dysfunction.",
          "judgment": "Yes",
          "reasoning": "The assays (solubility analysis and intracellular localization studies) are directly applicable to the disease mechanism defined in Step 1, as they address the molecular basis of parkin dysfunction.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "step_name": "Sub-step 3a: Basic Controls and Replicates",
              "extracted_paper_info": "The study analyzed 22 parkin point mutants, representing the majority of reported missense and nonsense variants. However, the paper does not explicitly describe the use of controls (e.g., known pathogenic/benign variants) or statistical replication.",
              "judgment": "No",
              "reasoning": "While the study analyzed multiple variants, the absence of explicit controls or statistical replication (e.g., OddsPath calculations) limits the strength of the evidence."
            },
            {
              "step_name": "Sub-step 3b: Accepted/Validated Assay",
              "extracted_paper_info": "The assays (solubility and localization analysis) are standard techniques in molecular biology and have been widely used in parkin-related studies.",
              "judgment": "Yes",
              "reasoning": "The assays are historically accepted and validated in the field, even if specific controls/replicates are not documented for this study."
            }
          ],
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "step_name": "Sub-step 4a: Statistical Analyses",
              "extracted_paper_info": "The paper does not report statistical analyses (e.g., p-values, OddsPath) to quantify the pathogenicity of individual variants.",
              "judgment": "No",
              "reasoning": "The absence of statistical metrics (e.g., OddsPath) prevents direct quantification of pathogenicity for individual variants."
            },
            {
              "step_name": "Sub-step 4b: No OddsPath Calculation",
              "extracted_paper_info": "The study analyzes 22 parkin mutants but does not explicitly report the number of benign/pathogenic control variants used.",
              "judgment": "Unknown",
              "reasoning": "The lack of explicit reporting on control variants limits the ability to determine the functional evidence strength."
            }
          ]
        }
      ],
      "evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    }
  ]
}